A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL
Clinical trial NCT02055820 · COMPLETED
Trial details
- NCT number
- NCT02055820
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-17
- Primary completion
- 2017-06-28
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.